High levels of certain intestinal bacteria, like Fusobacterium nucleatum, can promote tumor progression in patients with colorectal cancer. Now, scientists have revealed a unique mechanism through which excessive iron accumulation accelerates cancer progression in F. nucleatum-positive colorectal cancer.
Their findings show that iron accumulation enhances inflammatory responses in immune cells, promoting tumor growth and contributing to interpatient prognostic variability. These findings could support the development of new therapeutic strategies and drugs for colorectal cancer.
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths around the world. Recent studies have indicated that high levels of intestinal microbes such as Fusobacterium nucleatum in colorectal tumor tissues could lead to a poor prognosis in patients with CRC. However, factors associated with differences in prognosis among patients with F. nucleatum-positive CRC have so far remained unclear. As a result, targeted interventions against these tumors have remained limited. A possible answer could lie in the body’s iron levels, which often determine how the immune system responds to infections.
To explore the mechanisms contributing to tumor progression in CRC and identify case-specific signatures, especially in the context of F. nucleatum-positive CRC, researchers investigated the relationship between tumor progression and the body’s iron levels in samples of F. nucleatum-positive CRC.
Their study, recently published in the Journal of Clinical Investigation (JCI) Insight, revealed that excessive iron accumulation accelerates tumor progression in F. nucleatum-positive colorectal cancer.
“Focusing on the fact that CRC patients with high systemic iron levels show poor survival rates, we clarified the mechanism through which excess iron accelerates the progression of cancer,” says the study lead.
A healthy adult body contains about 3–5 g of iron, equivalent to the amount of iron present in an iron nail. While iron deficiency causes diseases such as anemia, excess iron has often been associated with diseases such as cancer. The researchers were inspired by their previous findings, which revealed that a disruption of iron homeostasis can alter tissue functions in the body.
Hence, to uncover the link between iron levels and CRC prognosis, they analyzed tumor tissue specimens from 204 patients diagnosed with stage I, II, or III F. nucleatum-positive or F. nucleatum-negative CRC. Simultaneously, the iron levels in the tumor tissues were also examined, along with the patients’ serum levels of “transferrin saturation” — an indicator of systemic iron status.
This first round of experiments revealed that both high levels of transferrin saturation and iron deposits within the tumor were associated with a worse overall survival (OS) in patients with F. nucleatum-positive CRC.
The rest of their study was geared towards understanding how iron affects CRC prognosis. One common link between iron metabolism and cancer progression is the modulation of immune responses, which are mediated by immune cells called macrophages that can both promote and inhibit tumors based on their molecular expression profiles. Hence, the researchers examined the effect of iron and F. nucleatum levels on the molecular expression profiles of macrophages using RNA sequencing.
They performed in vitro tests in cultured cells and found that F. nucleatum infection can activate the pro-tumor TLR4/NF-κB signaling pathway in macrophages, thus increasing the production of CCL8 — a protein that promotes tumor growth and progression. Together, the results showed that in F. nucleatum-positive CRC, the bacteria transform macrophages into pro-tumor cells expressing CCL8.
The role of iron in this process, however, remained unclear. To find the final piece of this puzzle, the researchers tested how changes in iron levels affect the increase in CCL8 caused by F. nucleatum.
Explains the senior author, “In other words, we asked if F. nucleatum can still induce CCL8 expression in macrophages if iron is absent.” Interestingly, the answer was that it couldn’t. When iron was removed, the production of CCL8 and other pro-tumor signaling molecules in macrophages was reduced considerably, meaning that they could no longer promote tumor development. This result explained why patients with F. nucleatum-positive CRC and lower levels of iron showed a better prognosis than their counterparts with high iron levels.
“Our research group has clarified that the combination of F. nucleatum infection and high levels of iron in the body accelerates the progression of CRC,” confirms the senior author. “This means that by targeting iron levels, survival rates could potentially be improved in this patient group,” the author adds.
https://insight.jci.org/articles/view/156802
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Firon-accelerates&filter=22&keep_no_swfupload=1
Combined effect of bacteria and iron levels on the progression of colorectal cancer
- 977 views
- Added
Latest News
SNUPN gene responsible for…
By newseditor
Posted 03 May
A brain circuit inhibits fo…
By newseditor
Posted 03 May
A hydrogel therapy defends…
By newseditor
Posted 03 May
Role of lipid droplets in A…
By newseditor
Posted 03 May
AI designs new drugs based…
By newseditor
Posted 03 May
Other Top Stories
Microglia not only prune synapses and neurons but myelin sheaths as…
Read more
Inhibiting a mitochondrial protein increases fat burning and reduce…
Read more
An anti-seizure molecule that activates brain potassium channel dis…
Read more
Interaction between uromodulin and E.coli in urinary tract infectio…
Read more
Why are memories attached to emotions so strong?
Read more
Protocols
Generation of rat forebrain…
By newseditor
Posted 03 May
Ultrasound-visible engineer…
By newseditor
Posted 03 May
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Publications
What Is Strep Throat?
By newseditor
Posted 04 May
Synergistic hyperactivation…
By newseditor
Posted 04 May
SNUPN deficiency causes a r…
By newseditor
Posted 03 May
Nausea-induced suppression…
By newseditor
Posted 03 May
Antiviral fibrils of self-a…
By newseditor
Posted 03 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar